Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis
Article Abstract:
It is observed that in placebo-controlled study, weekly fluconazole administered during a six-month period reduced the frequency of recurrent vulvavaginal candidiasis by more than 90 percent. In this study 387 women with recurrent vulvo-vaginal candidiasis were randomly assigned to receive treatment with fluconazole. Long-term weekly treatment with fluconazole can reduce the rate of recurrence of symptomatic vuvlavaginal candidiasis.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
The effect of vaginal candidiasis on the shedding of human immunodeficiency virus in cervicovaginal secretions
Article Abstract:
The influence of symptomatic vulvovaginal candidiasis on the shedding of HIV-1 in cervicovaginal secretions of HIV-1-infected women is examined. Vulvovaginal candidiasis is found to be associated with an increased number of copies of cell-associated and cell-free HIV-1 RNA in cervicovaginal secretions in HIV-infected women.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Valacyclovir therapy to reduce recurrent genital herpes in pregnant women. Comparative longitudinal study of cervical length and induced shortening changes among singleton, twin, and triplet pregnancies
- Abstracts: Risk factors for recurrent vulvovaginal candidiasis in women receiving maintenance antifungal therapy: results of a prospective cohort study
- Abstracts: Incidence and predictors of prolonged urinary retention after TVT with and without concurrent prolapse surgery